Cellulitis (Skin Infection): A Physician's Complete Guide

Every week in my practice, I see patients who waited too long with cellulitis. They assumed the redness on their leg was an allergic reaction, a bug bite, or something that would settle down on its own. By the time they came in, the infection had doubled in size and, in some cases, was already causing fever. Cellulitis moves fast. The good news is that when caught early and treated correctly, it almost always responds well to oral antibiotics.

Skin and soft tissue infections account for more than 14 million outpatient visits annually in the United States, with abscess and cellulitis being the most frequent diagnoses within that category.^[7] Despite how often we see them, cellulitis is also one of the most misdiagnosed conditions in emergency medicine — studies suggest that up to 30% of suspected cellulitis cases are actually something else entirely, most commonly lipodermatosclerosis or venous stasis dermatitis.^[6] Getting the diagnosis right matters because the wrong treatment wastes time and delays care for the real problem.

This guide covers everything I discuss with patients in the exam room: what cellulitis is, how to recognize it, how to tell it apart from other conditions that look similar, how we treat it based on current IDSA guidelines, and — critically — how to keep it from coming back.

What Is Cellulitis?

Cellulitis is a bacterial infection of the dermis (the deep layer of skin) and the subcutaneous tissues just beneath it. It is not a surface infection. That distinction is important because it explains both why it looks the way it does and why topical antibiotic creams have no meaningful role in treating it.

When bacteria breach the skin's outer barrier, they trigger an acute inflammatory response in the deeper tissue layers. Your immune system sends white blood cells to the area, producing the four classic signs: redness, warmth, swelling, and pain. The bacteria also release toxins that damage tissue, which is why prompt treatment prevents the infection from burrowing deeper into muscle or bone.

Cellulitis most commonly affects the lower legs, though it can occur anywhere on the body. In adults, roughly 70–80% of cases involve the lower extremity.^[6] The face, periorbital area, and hands are other sites that warrant particular attention, given the anatomical structures at risk if those infections spread.

Symptoms

The typical presentation of cellulitis follows a recognizable pattern. Most patients describe noticing redness that was small at first and then grew over 12–24 hours. By the time they're in my office, the area is warm to the touch, tender, and swollen — and often they can trace where the edge of the redness was yesterday compared to where it is today.

The Core Signs

• Redness (erythema): The skin appears red or pink, often with poorly defined borders that merge gradually into normal skin. Unlike erysipelas — a more superficial infection — classic cellulitis does not have a sharp, raised border.
• Warmth: The infected skin is noticeably warmer than surrounding tissue when you press the back of your hand to it.
• Swelling (edema): The area feels puffy or tight. In the lower leg, swelling may cause the skin to become tense and shiny.
• Pain or tenderness: The skin hurts to touch. Severe pain out of proportion to what you can see on the surface is a red flag for a deeper, more serious infection like necrotizing fasciitis.
• Spreading border: Active cellulitis spreads outward over hours to days. A border that is moving is still active infection, even if you are already on antibiotics. Treatment works when the border stops advancing — typically within 24–48 hours of starting the right antibiotic.

Systemic Symptoms

Fever, chills, fatigue, and body aches indicate the infection has triggered a systemic response. Their presence shifts the classification from mild to moderate or severe in the IDSA framework and typically means the infection has moved beyond simple outpatient management.^[1] Some patients also develop enlarged, tender lymph nodes near the affected area (regional lymphadenopathy) and red streaking along the skin that tracks toward lymph nodes (lymphangitis). Both are signs that the immune system is working hard and that the infection is moving — see a physician the same day.

Causes

Cellulitis is almost always caused by skin bacteria that get underneath the surface. Two organisms account for the overwhelming majority of cases.

Staphylococcus aureus — including both methicillin-sensitive (MSSA) and methicillin-resistant (MRSA) strains — is the most frequently implicated pathogen in purulent skin and soft tissue infections. In non-purulent cellulitis (no pus, no abscess), beta-hemolytic streptococci — particularly Group A Streptococcus (S. pyogenes) — are the primary cause.^[1] This distinction matters because it drives antibiotic selection: Streptococcus is reliably sensitive to beta-lactam antibiotics, while MRSA requires different coverage entirely.

How Bacteria Enter the Skin

Bacteria need a way in. They do not penetrate intact, healthy skin. The most common entry points are:

• Tinea pedis (athlete's foot): The macerated, cracked skin between the toes is the leading portal of entry for lower extremity cellulitis. Many patients have no idea they have a fungal infection until I examine their feet.
• Minor cuts, abrasions, and insect bites: Small breaks are sufficient. Scratching a mosquito bite, a paper cut, or a minor graze can introduce bacteria.
• Leg ulcers and venous stasis wounds: Chronic wounds are almost universally colonized with bacteria and provide direct access to deeper tissue.
• Surgical wounds and IV sites: Any procedure that disrupts the skin creates a potential entry point.
• Folliculitis: Infected hair follicles can serve as seeding sites for spreading infection.
• Injection drug use: Skin popping and IV drug use are associated with higher rates of MRSA and polymicrobial infection.

Risk Factors

Cellulitis is not random. Certain conditions consistently appear in the background of patients who develop it — especially those who get it repeatedly. Understanding these factors is as important as treating the acute infection, because recurrence rates are high when underlying issues go unaddressed.

• Diabetes mellitus: Elevated blood glucose impairs white blood cell function and slows the immune response. Diabetic patients also develop peripheral neuropathy, meaning minor foot injuries go unnoticed and unaddressed for longer. Skin infections in diabetics can also progress faster and may involve unusual organisms.^[3]
• Lymphedema: Lymphatic drainage removes fluid and carries immune cells to sites of infection. When lymphatic channels are damaged — from prior surgery, cancer treatment, trauma, or filariasis — fluid pools in the tissue, creating a protein-rich environment ideal for bacterial growth. Patients with lymphedema can develop cellulitis from bacteria with no obvious entry point.
• Obesity: Excess adipose tissue impairs lymphatic drainage in the legs and creates skin folds that trap moisture and reduce local immune surveillance. Obesity is independently associated with both developing and having recurrent cellulitis.^[3]
• Venous insufficiency: Chronic venous disease causes tissue congestion, hypoxia, and chronic skin breakdown that makes the lower legs particularly susceptible to infection.
• Prior cellulitis: Having one episode of cellulitis is one of the strongest predictors of future episodes. Tissue architecture changes after infection, lymphatic channels may be damaged, and underlying risk factors persist if not actively managed. Prior cellulitis raises the incidence rate substantially — one large cohort study found recurrence-related incidence nearly fivefold higher than in those without prior infection.^[7]
• Tinea pedis: Fungal infection of the feet — particularly between the toes — produces chronic skin fissuring that serves as a persistent bacterial entry point. This is one of the most treatable risk factors and arguably the most overlooked. I examine every cellulitis patient's feet, and a meaningful number have undiagnosed tinea pedis.
• Immunosuppression: HIV, corticosteroid therapy, chemotherapy, solid organ transplant recipients, and patients receiving biologics all have impaired defenses and may develop atypical or rapidly progressive infections.

Diagnosis

Cellulitis is a clinical diagnosis. There is no blood test or imaging study that definitively confirms it — the diagnosis is made by examining the skin and fitting the picture to the overall clinical context. This is both straightforward and, in practice, frequently wrong.

What I Look For

The characteristic triad is redness, warmth, and tenderness in a patient with a plausible entry point or recognized risk factors. I pay particular attention to:

• Whether the borders are defined or diffuse — sharp-raised borders suggest erysipelas, not typical cellulitis
• The presence of fluctuance (a soft, movable center indicating pus) — this means abscess, not pure cellulitis
• Whether there is a central clearing, satellite lesions, or irregular distribution — these suggest an alternative diagnosis
• Bilateral involvement — true cellulitis is almost always unilateral; bilateral lower leg redness in a patient with known heart failure or venous disease is far more likely to be stasis dermatitis
• Skin texture — tight, shiny, blistered, or darkened skin can indicate a more severe or necrotizing process

Marking the Border

One of the most useful things I do in the exam room — and one of the most practical things patients can do at home — is mark the border of the redness with a skin-safe marker or pen. Drawing a line around the leading edge, with the date and time noted, tells you whether the infection is spreading or shrinking when you check 12–24 hours later. If the redness is advancing beyond the line after 24–48 hours of antibiotics, that is a sign the treatment is not working and the patient needs re-evaluation.

When Imaging or Labs Are Needed

Most straightforward cellulitis cases need no additional workup. However, certain situations change that:

• CT scan or MRI: Ordered when necrotizing fasciitis is suspected — look for severe pain disproportionate to skin appearance, skin discoloration, crepitus (air in tissue), or rapid systemic deterioration. Imaging helps identify gas in soft tissue planes, though a negative CT does not rule out necrotizing infection in early stages.
• CBC and CMP: Reasonable for patients with fever, systemic symptoms, or those who are immunocompromised or diabetic. Elevated white cell count confirms inflammatory response. Elevated creatinine or glucose may affect antibiotic selection and disposition decisions.
• Blood cultures: As noted above, reserved for patients with systemic signs or immunosuppression.
• Ultrasound: Helpful when there is clinical uncertainty about whether a collection (abscess) is present beneath the cellulitis, particularly in obese patients where palpation is less reliable.

Cellulitis vs. Abscess vs. DVT

Getting the diagnosis right determines everything that follows. Three conditions are frequently confused with cellulitis, and each requires a different approach.

The DVT distinction deserves particular emphasis. DVT can produce unilateral leg swelling, warmth, and tenderness — a presentation that closely mimics early cellulitis. The key differences are that DVT skin is usually not as brightly red, and the redness tends to be blanchable (the red color disappears when you press on it) rather than the fixed, non-blanchable erythema of cellulitis. Still, if there is diagnostic uncertainty in a patient with risk factors for clotting — recent surgery, prolonged immobility, malignancy, oral contraceptive use — a Doppler ultrasound is the right call.^[5]

Stasis dermatitis is perhaps the most common misdiagnosis for bilateral lower extremity cellulitis. Stasis dermatitis is inflammation driven by chronic venous insufficiency — it produces redness, scaling, and itching in both legs, often in a classic "sock" distribution around the ankle and lower calf. It is not infectious and does not require antibiotics. Treating it as cellulitis delays the right treatment (compression, emollients, venous care) and exposes the patient to unnecessary antibiotics.

Treatment

Treatment decisions flow from two questions: Is this purulent (pus-forming) or non-purulent cellulitis? And are there risk factors for MRSA or signs of more severe infection? The IDSA 2014 skin and soft tissue infection guidelines provide a clear evidence-based framework for both.^[1]

First-Line Oral Antibiotics: Non-Purulent Cellulitis (No MRSA Risk)

For typical, non-purulent cellulitis in a patient without MRSA risk factors, streptococcal coverage is the target. Beta-lactam antibiotics work well:

The IDSA 2014 guidelines specify a 5-day course of antibiotics as the standard duration, extended if the infection has not clearly improved by that point.^[1] The old reflexive 10-day course is no longer supported by evidence for uncomplicated, non-purulent cellulitis. Shorter courses reduce side effects, cost, and contribution to antibiotic resistance without reducing efficacy when the diagnosis is correct.

When MRSA Coverage Is Needed

MRSA should be considered in cellulitis when any of the following are present:

• Prior documented MRSA infection
• Penetrating trauma as the entry point
• Known MRSA nasal colonization
• Injection drug use
• Systemic inflammatory response syndrome (SIRS) criteria met
• Failure to respond to 48–72 hours of a beta-lactam antibiotic
• Known community with high CA-MRSA prevalence

For severe infections requiring hospitalization, intravenous vancomycin — or alternatively daptomycin or linezolid — provides MRSA coverage while awaiting culture results. Once the patient is clinically improving and tolerating oral intake, step-down to an appropriate oral agent is appropriate.^[1]

Elevation and Supportive Care

Elevation of the affected limb above heart level reduces swelling and improves antibiotic delivery to the infected tissue by decreasing venous congestion. The IDSA guidelines specifically recommend elevation of the affected area along with treatment of any underlying predisposing conditions — both are given a "strong" recommendation.^[1] Cold compresses or cool water may reduce discomfort, but heat should be avoided as it can increase bacterial proliferation.

The guidelines also note that systemic corticosteroids (such as prednisone 40 mg daily for 7 days) could be considered in non-diabetic adults with cellulitis, as a small number of studies suggest modestly faster symptom resolution. This is a weak recommendation and is not standard practice in most settings — the risk of steroid-related complications generally does not justify routine use.^[1]

When to See a Doctor

Knowing where to go — and how fast — is one of the most practical decisions you face when you notice a red, swollen area on your skin. Here is the framework I use when talking with patients.

What I tell patients is this: a telehealth visit is genuinely appropriate for many cellulitis presentations. You do not automatically need an emergency room. But if there is any doubt — if the redness is moving fast, if you feel systemically unwell, or if you are in a high-risk group — go in person and go quickly.

Red Flags

Necrotizing fasciitis — sometimes called "flesh-eating bacteria" in the media — is rare but worth understanding because the window for effective surgical intervention is narrow. The bacteria involved (most often Group A Streptococcus, Clostridium species, or mixed organisms) produce enzymes that destroy the fascia and subcutaneous tissue faster than the skin surface shows. Pain that seems completely out of proportion to what the skin looks like is the most important clinical clue. If you or someone else describes the pain as "the worst ever" and the redness seems almost unremarkable in comparison, that is an emergency.

Prevention

Cellulitis recurrence rates are high — studies estimate 8–20% of patients will have another episode within a year, and once you have had two or three infections, the pattern tends to continue unless the underlying factors are actively managed.^[3] Prevention is where the most meaningful long-term gains are made.

Treat Tinea Pedis First

Every patient I see with recurrent lower extremity cellulitis gets a careful foot exam, and many have tinea pedis they were either unaware of or not treating consistently. Interdigital tinea pedis — the classic "athlete's foot" between the toes — creates chronic skin fissuring that is the most common bacterial entry point for cellulitis in the lower leg. Topical terbinafine or clotrimazole applied once daily for one week has high cure rates for interdigital tinea. Systemic antifungal therapy (oral fluconazole or itraconazole) is used for resistant or widespread infection.^[3]

Compression for Lymphedema and Venous Insufficiency

Chronic leg swelling dramatically increases cellulitis risk by creating a stagnant, protein-rich tissue environment that bacteria thrive in. A randomized trial found that compression stocking therapy (providing at least 23 mmHg of pressure) in patients with chronic leg edema and prior cellulitis reduced recurrence from 40% in controls to 15% in the compression group — a number needed to treat of 4.^[5] Over-the-counter compression stockings at 20–30 mmHg are available at most pharmacies. Compression should generally be started after the acute cellulitis has resolved.

Skin Care and Barrier Maintenance

Dry, cracked skin — particularly on the feet and lower legs — loses its protective barrier function. Regular application of emollients (unscented moisturizers) to the lower extremities reduces fissuring and helps maintain intact skin. Gentle daily washing, particularly between the toes, removes bacteria before they can establish themselves. Patients with venous stasis dermatitis should have this treated actively, since inflamed skin is far more permeable than healthy skin.

Managing Systemic Risk Factors

Blood glucose control in diabetics reduces both the frequency and severity of skin infections. Weight management, though difficult, reduces the lymphatic and venous stasis that drives lower extremity cellulitis. Patients with lymphedema benefit from working with a lymphedema therapist to optimize drainage technique and compression wrapping.

Antibiotic Prophylaxis for Recurrent Cases

For patients who continue to have 3–4 episodes per year despite addressing modifiable risk factors, the IDSA 2014 guidelines support prophylactic antibiotics — oral penicillin or erythromycin twice daily for 4–52 weeks, or intramuscular benzathine penicillin every 2–4 weeks.^[1] A 2013 UK trial (the PATCH trial) confirmed that low-dose penicillin prophylaxis reduced recurrence by about 45% during the treatment period. This is viewed as a later-line option — a bridge while underlying conditions are treated — rather than a substitute for addressing root causes.

Frequently Asked Questions